Opinion

Video

Expert Insights on Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer

Author(s):

Elizabeth R. Plimack, MD, MS, FASCONeeraj Agarwal, MD

Experts on muscle-invasive bladder cancer respond to recent data in adjuvant therapy that were presented at ASCO GU 2024.

Related Videos
5 KOLs are featured in this program
5 KOLs are featured in this program
Brian I. Rini, MD, FASCO
A panel of 4 experts on lung cancer
A panel of 4 experts on lung cancer
A panel of 5 experts on breast cancer
5 KOLs are featured in this peer exchange
A panel of 5 experts on breast cancer
5 KOLs are featured in this peer exchange
Mazyar Shadman, MD, MPH
Related Content
Jennifer Doherty, PhD, MS
July 23rd 2024

Landmark Study Shows Elevated Cancer Risk For Women With Endometriosis

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

J. Ryan Mark, MD, FACS, of Fox Chase Cancer Center
July 19th 2024

Fox Chase Cancer Center Welcomes Dr. J. Ryan Mark

Carrie L. Kitko, MD, associate professor, pediatrics, medical director, the Pediatric Stem Cell Transplantation Program, the Ingram Professor of Pediatric Oncology, Monroe Carell Jr. Children’s Hospital at Vanderbilt; Sagar S. Patel, MD, director, Communications and Media Relationships, the Division of Hematology, the University of Utah Huntsman Cancer Institute
February 19th 2024

Kitko and Patel Emphasize the Importance of GVHD Research and Awareness

Toni Choueiri, MD
July 18th 2024

Nivolumab/Tivozanib Fails to Improve PFS in Advanced RCC After Prior Immune Checkpoint Inhibition

RCC | Image Credit: © SciePro - stock.adobe.com
July 17th 2024

NCCN Updates Kidney Cancer Clinical Practice Guidelines